Stay updated on EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.

Latest updates to the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedPage revision updated from v3.6.5 to v3.6.6, indicating a maintenance/patch update to the page rendering.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, signaling an update to the site's documentation/UI. The update does not modify the study content, eligibility criteria, or how a user interacts with the page.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page revision has been updated from v3.6.3 to v3.6.4, reflecting a minor update to the page’s metadata and/or content.SummaryDifference0.0%

- Check72 days agoChange DetectedThe site revision tag changed from v3.6.2 to v3.6.3, indicating a minor software update to the page. This change does not alter study content or key functionality.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page shows Revision: v3.6.2, replacing the previous Revision: v3.6.0. This indicates a software or template update rather than a change to study details.SummaryDifference0.0%

- Check94 days agoChange DetectedThe page adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment status note ('No longer looking for participants'). The Intervention/Treatment heading is updated from 'Intervention / Treatment' and the site revision is updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EphB4-HSA Fusion Protein and Pembrolizumab Clinical Trial page.